Three new exon 10 glucose-6-phosphate dehydrogenase mutations

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Hereditary non-spherocytic hemolytic anemia (HNSHA) is a group of inherited disorders characterized by red blood cell destruction.
• Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder that can lead to hemolytic anemia.
• Understanding G6PD gene mutations is crucial for diagnosing and managing HNSHA.

Observation:

• Three novel mutations in the G6PD gene were identified in patients with HNSHA.
• These mutations, named G6PD Calvo Mackenna, G6PD Riley, and G6PD Wisconsin, involve specific nucleotide transitions and transversions.
• All identified mutations are located within exon 10 of the G6PD gene, a region known to harbor HNSHA-associated mutations.

Findings:

• G6PD Calvo Mackenna results from an A-to-G transition at cDNA nucleotide 1138, substituting valine for isoleucine at amino acid 380.
• G6PD Riley arises from a T-to-C transition at cDNA nucleotide 1139, changing isoleucine to threonine at amino acid 380.
• G6PD Wisconsin is caused by a C-to-G transversion at cDNA nucleotide 1177, replacing arginine with glycine at amino acid 393.

Implications:

• The identification of these new mutations expands the known spectrum of G6PD gene defects associated with HNSHA.
• The clustering of mutations in exon 10 suggests this region is critical for G6PD enzyme function.
• This research contributes to a comprehensive catalog of G6PD mutations, aiding in genetic counseling and diagnostic efforts.